This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087054707311654v1 12/2/115    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kollins, S. H. Search for Related Content PubMed PubMed Citation Articles by Kollins, S. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMPHETAMINE METHYLPHENIDATE Medline Plus Health Information Attention Deficit Hyperactivity Disorder Drug Abuse Social Bookmarking                         What's this?

ADHD, Substance Use Disorders, and Psychostimulant Treatment: Current Literature and Treatment Guidelines

^* To whom correspondence should be addressed. E-mail: kolli001{at}mc.duke.edu.

	Abstract

Objective: This review explores the relationship between ADHD and substance use disorder (SUD), factors that determine the abuse potential of psychostimulants, and strategies for identifying and treating at-risk ADHD patients. Method: This study uses a Medline review of literature. Results: Psychostimulants, such as methylphenidate and amphetamines, are effective first-line pharmacotherapy for ADHD and when used appropriately in individuals with ADHD do not appear to be frequently abused by patients. Diversion and misuse of prescription stimulants are growing concerns, especially among young adults and college students. Short-acting psychostimulant formulations may have higher potential for abuse, misuse, and diversion, but more data are needed to substantiate this observation. Nonstimulant treatments for ADHD may be considered for patients at particularly high risk for substance use, misuse, or diversion of stimulants. Conclusion: In treating patients with ADHD and comorbid substance use, psychostimulants may be a useful pharmacologic alternative. However, the risks of such treatment with high-risk populations must be considered alongside potential benefits. (J. of Att. Dis. XXXX; XX (X) xx-xx)

First published on January 11, 2008, doi:10.1177/1087054707311654

Journal of Attention Disorders 2008;12:115.

A more recent version of this article appeared on September 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. J. DuPaul, L. L. Weyandt, S. M. O'Dell, and M. Varejao College Students With ADHD: Current Status and Future Directions J Atten Disord, November 1, 2009; 13(3): 234 - 250. [Abstract] [PDF]